These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7494816)

  • 41. The influence of hydro-alcoholic media on hypromellose matrix systems.
    Levina M; Vuong H; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2007 Oct; 33(10):1125-34. PubMed ID: 17963114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D; Vrečer F
    Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets.
    Yan G; Li H; Zhang R; Ding D
    Drug Dev Ind Pharm; 2000 Jun; 26(6):681-6. PubMed ID: 10826117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The consequence of the chemical composition of HPMC in matrix tablets on the release behaviour of model drug substances having different solubility.
    Viridén A; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Jan; 77(1):99-110. PubMed ID: 21081160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of HPMC substituent pattern on water up-take, polymer and drug release: An experimental and modelling study.
    Caccavo D; Lamberti G; Barba AA; Abrahmsén-Alami S; Viridén A; Larsson A
    Int J Pharm; 2017 Aug; 528(1-2):705-713. PubMed ID: 28636894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1167-74. PubMed ID: 22540355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Designing HPMC matrices with improved resistance to dissolved sugar.
    Williams HD; Ward R; Culy A; Hardy IJ; Melia CD
    Int J Pharm; 2010 Nov; 401(1-2):51-9. PubMed ID: 20858538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
    Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.
    Maggi L; Bruni R; Conte U
    Int J Pharm; 2000 Feb; 195(1-2):229-38. PubMed ID: 10675700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rheological characterization of xanthan gum and hydroxypropylmethyl cellulose with respect to controlled-release drug delivery.
    Talukdar MM; Vinckier I; Moldenaers P; Kinget R
    J Pharm Sci; 1996 May; 85(5):537-40. PubMed ID: 8742947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
    Ebube NK; Jones AB
    Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. I. Pulse-field-gradient spin-echo NMR study of sodium salicylate diffusivity in swollen hydrogels with respect to polymer matrix physical structure.
    Ferrero C; Massuelle D; Jeannerat D; Doelker E
    J Control Release; 2008 May; 128(1):71-9. PubMed ID: 18433910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydrophilic matrices for controlled drug delivery: an improved mathematical model to predict the resulting drug release kinetics (the "sequential layer" model).
    Siepmann J; Peppas NA
    Pharm Res; 2000 Oct; 17(10):1290-8. PubMed ID: 11145237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Matrices containing NaCMC and HPMC 2. Swelling and release mechanism study.
    Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
    Int J Pharm; 2007 Mar; 333(1-2):143-51. PubMed ID: 17240091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of a binary polymer system in drug release rate modulation. 1. Characterization of release mechanism.
    Kim H; Fassihi R
    J Pharm Sci; 1997 Mar; 86(3):316-22. PubMed ID: 9050799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double-layered mucoadhesive tablets containing nystatin.
    Llabot JM; Manzo RH; Allemandi DA
    AAPS PharmSciTech; 2002; 3(3):E22. PubMed ID: 12916937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
    Varshosaz J; Tavakoli N; Kheirolahi F
    AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimization of sustained-release propranolol dosage form using factorial design and response surface methodology.
    Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC
    Biol Pharm Bull; 2004 Oct; 27(10):1626-9. PubMed ID: 15467208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.